跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
None - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
None
Approved
STANDARD
None
Hospira, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8d1fcc0df623eb0b
Company
Hospira, Inc.
Type
Standard
Approval Details
Approval Id
8d1fcc0df623eb0b
Drug Approval Philippines Name
None
Product Name
None
Registration Number
DR-XY23120
Brand Name
None
Generic Name
Dobutamine (As Hydrochloride)
Dosage Form
Solution For Injection (I.V.)
Dosage Strength
12.5mg/ mL
Manufacturer
Hospira, Inc.
Importer
Pfizer, Inc.
Company Detail Path
/organization/hospira-inc-united-states
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
27 June 2022
Expiry Date
21 July 2027
Pharmacologic Category
Adrenergic and Dopaminergic agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8d1fcc0df623eb0b
Type
Standard
Back to Philippines FDA Approvals